U.S. Colorectal Cancer Screening Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Te....

U.S. Colorectal Cancer Screening Market Leaders

Polymedco Inc.
Eiken Chemical Co. Ltd.
Sysmex Corporation
Quidel Corporation
Novigenix SA

*Disclaimer: Major players are listed in no particular order.

U.S. Colorectal Cancer Screening Market - Company List

Polymedco Inc.
Eiken Chemical Co. Ltd.
Sysmex Corporation
Quidel Corporation
Novigenix SA
Hemosure Inc.
Exact Sciences Corp.
Epigenomics Inc.
Olympus Corporation
Clinical Genomics Technologies Pty Ltd.
Abbott
F. Hoffmann-La Roche Ltd
Siemens Healthineers
Koninklijke Philips N.V.
Thermo Fisher Scientific Inc.
Illumina, Inc.
Myriad Genetics Inc.
QIAGEN
Merck KGaA

U.S. Colorectal Cancer Screening Market Report Snapshots

Buy Now